WASHINGTON (Dispatches) -- President Donald Trump has sent a civilian nuclear cooperation agreement with Saudi Arabia to Congress for review, conditioning the pact on Riyadh’s entry into the Abraham Accords with Israel.
The 30-year agreement, valued in the tens of billions of dollars, would allow U.S. firms including Westinghouse to supply AP1000 reactors to the kingdom. 
However, critics say the text contains no restrictions on uranium enrichment or spent fuel reprocessing inside Saudi Arabia — two pathways toward nuclear weapons capability.
Under the deal, a joint U.S.-Saudi study could determine the feasibility of building a uranium enrichment facility in the kingdom, operated by American firms in a so-called “black box” arrangement. 
The agreement does not require Saudi Arabia to sign the International Atomic Energy Agency’s Additional Protocol, meaning the IAEA would lack full oversight of Riyadh’s nuclear activities.
The deal has drawn sharp criticism as a glaring double standard, given that Trump has justified his war on Iran precisely on the grounds of preventing Tehran from acquiring nuclear weapons — despite Iran being an NPT signatory and U.S. intelligence repeatedly assessing it is not actively seeking to weaponize its program.
Critics point out that while the U.S. has bombed peaceful Iranian nuclear facilities and assassinated its scientists, it is now offering Saudi Arabia — a non-NPT signatory with no civilian nuclear infrastructure — a pathway to enrichment capabilities.
Experts warn the agreement breaks the “gold standard” set by the 2009 U.S.-UAE nuclear pact, which required Abu Dhabi to forgo domestic enrichment and accept strict IAEA oversight. 
“This is hardly ideal if you’re serious about no enrichment,” said Henry Sokolski of the Nonproliferation Policy Education Center.
The deal could trigger a regional nuclear arms race, analysts say, with Turkey, Egypt and the UAE potentially demanding similar concessions.
Trump announced on July 23 that the agreement would move forward only if Saudi Arabia joins the Abraham Accords.  
Under U.S. law, Congress has 90 session days to review the deal. A rejection could be vetoed by Trump, requiring a two-thirds majority in both chambers to override. With Republicans controlling Congress, blocking the agreement appears difficult.
The terrorist Israeli regime, blindsided by the deal, has expressed deep alarm, with opposition leader Naftali Bennett calling it a “serious strategic failure” that could erode Israel’s regional nuclear monopoly.